A multi-centre analysis of the impact of updated risk stratification on follow-up of gastric gastro-intestinal stromal tumours in the post-imatinib era. [electronic resource]
Producer: 20120625Description: 484-9 p. digitalISSN:- 1532-2157
- Adult
- Aged
- Antineoplastic Agents -- therapeutic use
- Benzamides
- Chemotherapy, Adjuvant
- Female
- Follow-Up Studies
- Gastrectomy
- Gastrointestinal Stromal Tumors -- drug therapy
- Humans
- Imatinib Mesylate
- Kaplan-Meier Estimate
- Male
- Middle Aged
- Neoplasm Recurrence, Local -- prevention & control
- Neoplasm Staging
- Piperazines -- therapeutic use
- Prospective Studies
- Pyrimidines -- therapeutic use
- Risk Assessment
- Risk Factors
- Stomach Neoplasms -- drug therapy
- Watchful Waiting
No physical items for this record
Publication Type: Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.